Bronşiolit
Özet
Referanslar
Angurana SK, Williams V, Takia L. Acute Viral Bronchiolitis: A Narrative Review. J Pediatr Intensive Care. 2023;12:79–86.
Ralston SL, Lieberthal AS, Meissner HC, et al; American Academy of Pediatrics. Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis. Pediatrics. 2014;134(5):e1474-e1502 .
Florin TA, Plint AC, Zorc JJ. Viral Bronchiolitis. Lancet. 2017;389(10065):211-224 .
Meissner HC. Viral Bronchiolitis in Children. New England Journal of Medicine. 2016;374(1):62-72
Sanders SL, Agwan S, Hassan M, van Driel ML, Del Mar CB. Immunoglobulin Treatment for Hospitalised Infants and Young Children with Respiratory Syncytial Virus Infection. Cochrane Database Syst Rev. 2019;8:CD009417.
Zhang L, Mendoza-Sassi RA, Wainwright C, Klassen TP. Nebulised Hypertonic Saline Solution for Acute Bronchiolitis in Infants. Cochrane Database Syst Rev. 2017;12:CD006458
Centers for Disease Control and Prevention (CDC). Respiratory Syncytial Virus (RSV): Clinical Guidance for Infants and Young Children. Erişim tarihi: 8 Ocak 2025. https://www.cdc.gov/rsv/hcp/vaccine-clinical-guidance/infants-young-children.html.
Merck. Merck’s Clesrovimab (MK-1654): An Investigational Respiratory Syncytial Virus (RSV) Preventative Monoclonal Antibody. Erişim tarihi: 8 Ocak 2025. https://www.merck.com/news/mercks-clesrovimab-mk-1654-an-investigational-respiratory-syncytial-virus-rsv-preventative-monoclonal-antibody-significantly-reduced-incidence-of-rsv-disease-and-hospitalization-in-heal/.
Referanslar
Angurana SK, Williams V, Takia L. Acute Viral Bronchiolitis: A Narrative Review. J Pediatr Intensive Care. 2023;12:79–86.
Ralston SL, Lieberthal AS, Meissner HC, et al; American Academy of Pediatrics. Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis. Pediatrics. 2014;134(5):e1474-e1502 .
Florin TA, Plint AC, Zorc JJ. Viral Bronchiolitis. Lancet. 2017;389(10065):211-224 .
Meissner HC. Viral Bronchiolitis in Children. New England Journal of Medicine. 2016;374(1):62-72
Sanders SL, Agwan S, Hassan M, van Driel ML, Del Mar CB. Immunoglobulin Treatment for Hospitalised Infants and Young Children with Respiratory Syncytial Virus Infection. Cochrane Database Syst Rev. 2019;8:CD009417.
Zhang L, Mendoza-Sassi RA, Wainwright C, Klassen TP. Nebulised Hypertonic Saline Solution for Acute Bronchiolitis in Infants. Cochrane Database Syst Rev. 2017;12:CD006458
Centers for Disease Control and Prevention (CDC). Respiratory Syncytial Virus (RSV): Clinical Guidance for Infants and Young Children. Erişim tarihi: 8 Ocak 2025. https://www.cdc.gov/rsv/hcp/vaccine-clinical-guidance/infants-young-children.html.
Merck. Merck’s Clesrovimab (MK-1654): An Investigational Respiratory Syncytial Virus (RSV) Preventative Monoclonal Antibody. Erişim tarihi: 8 Ocak 2025. https://www.merck.com/news/mercks-clesrovimab-mk-1654-an-investigational-respiratory-syncytial-virus-rsv-preventative-monoclonal-antibody-significantly-reduced-incidence-of-rsv-disease-and-hospitalization-in-heal/.
